RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announces the sale of Excelsior Medical Corporation to ICU Medical, Inc. ICU Medical develops, manufactures and sells medical technologies used in infusion therapy, oncology and critical care applications.
Excelsior, based in Neptune, N.J., is a leading provider of intraluminal catheter care and disinfection products. The company's goal is to help clinicians reduce the risk of infection, avoid medication errors and lower healthcare costs. Excelsior has developed and commercialized the innovative SwabCap® and SwabFlush™ products, and is a leader in pre-filled saline and heparin flush syringes. The company also manufactures and sells pharmacy filling and syringe infusion pump and tubing systems. In connection with this transaction, ICU Medical has agreed to sell the pre-filled syringe and SwabFlush™ businesses to Medline Industries, Inc. ICU Medical will retain the SwabCap® and pumps and tubing businesses.
"Excelsior's management team has done an excellent job of building a fully-integrated platform in intraluminal catheter care," says Lester B. Knight, founding partner of RoundTable and chairman of Excelsior. "We believe that ICU Medical and Medline will be strong strategic partners for the company, its employees, and customers going forward."
Steve Thornton, CEO of Excelsior Medical Corporation, says, "RoundTable has been a tremendous partner for Excelsior since their initial acquisition of the Company in 2004. They have provided key access to customers and helped expand our product offerings. We look forward to partnering with ICU Medical and Medline to continue to achieve our growth objectives."
Robert W. Baird & Co. acted as exclusive financial advisor to Excelsior Medical Corporation and Sidley Austin LLP acted as exclusive legal advisor to RoundTable in this transaction.
Source: RoundTable Healthcare Partners
Long COVID: Urgent Findings, Including Brain Alterations, Call for Renewed Public Health Focus
October 21st 2024New research highlights long COVID’s global impact, cognitive decline, and societal consequences, urging renewed focus on prevention, including vaccination, mask use, and better air quality.